Results 111 to 120 of about 1,574,238 (214)
Supplemental Material, JCPT_Oct_2016_225_revised_CV_effect_revised_supplemental_materials_24_Jan_2018 for Cardiovascular Safety of the Selective μ-Opioid Receptor Antagonist Naloxegol: A Novel Therapy for Opioid-Induced Constipation by William B.
Raj Tummala (5296499) +4 more
core +1 more source
Proliferation of the term “emotion dysregulation” in child psychopathology parallels the growing interest in processes that influence negative emotional reactivity. While it commonly refers to a clinical phenotype where intense anger leads to behavioral dyscontrol, the term implies etiology because anything that is dysregulated requires an impaired ...
Joseph C. Blader +2 more
wiley +1 more source
N‐methyl‐D‐aspartate receptor antagonists for controlling pain in dogs
This is a mini review published by the World Small Animal Veterinary Association's Pain Committee. This article provides an assessment of the scientific evidence of N‐methyl‐d‐aspartate receptor antagonists for controlling pain in dogs while identifying current knowledge gaps.
P. W. Kronen +6 more
wiley +1 more source
BackgroundNaloxone reverses opioid-induced respiratory depression (RD) but may precipitate withdrawal in opioid-dependent individuals. Although both have been studied separately, their concentration-response relationships have not been described within a
Albert Dahan +13 more
doaj +1 more source
Summary Parasomnias and sleep‐related movement disorders (SRMD) are major causes of sleep disorders and may be drug induced. The objective of this study was to conduct a systematic review of the literature to examine the association between drug use and the occurrence of parasomnias and SRMD.
Sylvain Dumont +5 more
wiley +1 more source
Background: Reproducible patterns of atypical functional connectivity (FC) of sensorimotor and higher-order networks have previously been identified in the autistic brain. However, the neurosignaling pathways underpinning these differences remain unclear.
Mihail Dimitrov +18 more
doaj +1 more source
Abstract This paper analyzes two disparate experiences of buprenorphine, a medication for opioid addiction, in California. Within the context of the U.S. War on Drugs and after decades of criminalization, buprenorphine represents a shift toward outpatient medical treatment of opioid addiction, but it has been unequally distributed and experienced ...
Lauren Textor
wiley +1 more source
Background Ketamine produces rapid antidepressant effects in treatment‐resistant depression (TRD), but these benefits diminish within days. Whether intermittent theta‐burst stimulation (iTBS) can sustain ketamine response and whether such effects are associated with changes in large‐scale brain networks are unclear.
Tung‐Ping Su +7 more
wiley +1 more source
Mastoparan reduces the supraspinal analgesia mediated by μ/δ-opioid receptors in mice
Intracerebroventricular (i.c.v.) administration of the venom peptide, mastoparan, to mice decreased to a limited extent opioid-induced supraspinal analgesia in a non-competitive fashion.
Sánchez-Blázquez, Pilar +3 more
core +1 more source
Abstract Constipation affects approximately 20% of the US population, with diverse treatment options available due to the unclear onset and causes of the condition. Recently, focused ultrasound (FUS) has been proposed as a novel, non‐invasive peripheral neuromodulatory treatment that may reduce this inflammation.
Dia Shah +11 more
wiley +1 more source

